Psycho physical test in normal individual and diabetic patients with and without diabetic retinopathy: comparative study

Sapna Raghuwanshi, Rashmi Kumar, Shivkumar Raghuwanshi


Purpose: To investigate the differentiating ability of psycho physical test which include contrast sensitivity function (CSF), dark adaptation (DA) and best corrected visual acuity (BCVA) in detecting functional losses in diabetic participants with and without retinopathy. Methods: In this cross-sectional study we examined 90 patients in L.N. Medical College and J.K Hospital, Kolar road, Bhopal between June to November 2017 including 60 diabetic patients (30 with retinopathy and 30 without retinopathy in fundus photography) with 30 control non-diabetic subjects matched for age and sex. The diabetic participants were sub grouped according to the level of retinopathy (EDTRS classification). CSF was examined by means of pelli robson chart in each eye; DA was assessed with photostress test and BCVA by Snellen chart. Results: When comparing visual performance of the right and left eyes of patients in each group, CSF was significantly lower in the diabetic eyes with retinopathy than in the normal eyes or the diabetic eyes without retinopathy. Comparing to control group, there was a statistically significant CSF loss in the diabetic eyes without retinopathy (P<0.05). The mean log MAR BCVA and DA abnormalities were significantly higher in the diabetic eyes with retinopathy than in the normal eyes or the diabetic eyes without retinopathy (P<0.001). There was no significant difference observed in mean log MAR BCVA and DA between those of diabetic eye with out retinopathy compared to the control group. Conclusion: There was significant difference observed in visual performance of those diabetics with retinopathy compared to those without. The findings also suggest that the appropriate combination of existing tests can be a useful method of improving screening accuracy in diabetic patients.

Full Text:



Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indianscenario. Indian J Med Res. 2007 Mar;125(3):217-30.

Wild S, Roglic G, Green A, Sicree R, King H. Globalprevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care.2004 May; 27(5):1047-53.

Yau JW, Rogers SL, Kawasaki Ret al.Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and majorrisk factors of diabetic retino-pathy. Diabetes Care. 2012Mar;35(3):556-64. doi: 10. 2337 / dc11-1909. Epub2012Feb1.

Ding J, Wong TY. Currentepidemiology of diabetic retinopathy and diabeticmacular edema. Curr Diab Rep. 2012Aug; 12(4): 346-54. doi: 10.1007/s 11892-012-0283-6.

Romero-Aroca P. Managing diabetic macular edema: the leading cause of diabetes blindness. World J Diabetes. 2011 Jun 15; 2(6): 98–104. Published online 2011 Jun 15. doi: 10.4239/wjd.v2.i6.98.

Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wis consin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retino-pathy when age at diagnosis is less than 30years. Arch Ophthalmol.1984Apr;102(4):520-6.

Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris III FL Klein R. Diabetic retinopathy. Diabetes Care 1998; 21(1): 143–156.

Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, LaPorte RE, Kuller LH. Prevalence of complications in IDDM by sex and duration. Pittsburgh Epidemiology of Diabetes Complications StudyII. Diabetes. 1990 Sep; 39(9):1116-24.

Frost-Larsen K, Larsen HW. Nyctometry - a new screening method for selection of patients with simpledia betic retinopathy who are at risk of developing prolife rative retinopathy. Results of a 3-year follow-up. ActaOphthalmol (Copenh). 1983 Jun;61 (3): 353-61.

A Paul Chous, 1 Stuart P Richer, 2 Jeffry D Gerson, 3 Renu A Kowluru4. The Diabetes Visual Function Supplement Study (DiVFuSS). BJO Online First, published on June 18, 2015 as 10.1136/bjophthalmol-2014306534.

Stavrou EP, Wood JM. Lettercontrast sensitivity changes in early diabetic retinopathy. Clin Exp Optom. 2003 May;86(3):152-6.

Olafsdóttir E, Stefánsson E. Biennial eye screening in patients with diabetes without retinopathy: 10-year experience. Br J Ophthalmol. 2007 Dec; 91 (12):1599-601. Epub 2007 Jul 12.

Moloney J, Drury MI. Retinopathy and retinalfunction in insulin-dependent diabetes mellitus. Br J Ophthalmol. 1982 Dec; 66 (12):759-61.

Jackson GR, Barber AJ. Visual dysfunction associated with diabetic retinopathy. Curr Diab Rep. 2010 Oct; 10(5): 380-4. doi: 10.1007/s11892-010- 0132-4.

Beszédesová N, Budinská E, Skorkovská S. [Functional integrity of neural retina in 2. type diabetics]. Cesk Slov Oftalmol. 2009 Jul; 65 (4): 124-30.

Pomerance GN, Evans DW. Test-retest reliability of the CSV-1000 contrasttest and its relationship to glaucoma therapy. Invest Ophthalmol Vis Sci. 1994 Aug; 35(9):3357-61.

Scanlon PH, Foy C, Chen FK. Visual acuity measurement and ocular co-morbidity in diabetic retinopathy screening. Br J Ophthalmol. 2008 Jun;92 (6): 775-8. doi: 10.1136/bjo.2007.128561. Epub 2008 Mar 20.

Woods RL, Wood JM. The role of contrast sensitivity charts and contrast letter charts in clinical practice. Clin Exp Optom1995;78:2:43-57.

Moss SE, Klein R, Klein BE. The incidence of vision lossin adiabetic population. Ophthal-mology. 1988 Oct;95(10):1340-8.

Ismail GM, Whitaker D. Early detection of changes in visual function in diabetes mellitus. Ophthalmic Physiol Opt.1998Jan;18(1):3-12.

Sokol S, Moskowitz A, Skarf B, Evans R, Molitch M, Senior B. Contrast sensitivity in diabetics with and without background retinopathy. Arch Ophthalmol. 1985 Jan; 103 (1): 51-4.

Shaili Misra,1Sandeep Saxena, Poonam Kishore, 1Shashi K. Bhasker,1Arvind Misra,2 and Carsten H. Meyer3, Association of contrast sensitivity with Log MAR visual acuity and glycosylated hemoglobin in non-insulin dependent diabetes mellitus, J Ocul Biol Dis Infor. 2010 Jun; 3(2): 60–63. Published online 2010 Nov 3. doi: 10.1007/s12177-010-9056-0.

Della Sala S, Bertoni G, Somazzi L, Stubbe F, Wilkins AJ. Impairedcontrast sensitivity in diabetic patients with and without retinopathy: a new technique for rapid assessment. Br J Ophthalmol. 1985 Feb;69 (2): 136-42.

Jackson GR, Scott IU, Quillen DA, Walter LE, Gardner TW. Innerretinal visual dysfunction is a sensitive marker of non-prolife rative diabetic retinopathy. Br J Ophthalmol. 2012 May; 96 (5):699-703. doi: 10. 1136/bjophthalmol-2011-300467. Epub 2011 Dec 15.

Marsden J, Stevens S, Ebri A. How to measure distancevisual acuity. Community Eye Health. 2014; 27(85):16.

Pelli, D. G., Robson, J. G., & Wilkins, A. J. The design of a new letter chart for measuring contrast sensitivity. Clinical Vision Sciences, (1988). 2(3),187-199).

Lavingia B. Photostress test. Indian J Ophthalmol. 1983 May; 31(3):183.

Di Leo MA, Caputo S, Falsini B, Porciatti V, Minnella A, Greco AV, Ghirlanda G. Nonselectiveloss of contrast sensitivity in visualsystemtesting in early type I diabetes. Diabetes Care. 1992 May; 15(5):620-5.

Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A. Detecting and treatingretinopathy in patients with type I diabetes mellitus. A health policy model. Ophthalmology. 1990 Apr; 97 (4): 483-94; discussion 494-5.

Noticewala V, Manisha Shastri, A study of contrast sensitivity changes in normal individual and diabetic patients with and without diabetic retinopathy, Int J Res Med Sci. 2017 Nov;5(11):4840-4845.

JavadHeravian, PhD1 • Naser Shoeibi, MD2 • Abbas Azimi, PhD1 • Shayesteh Yasini, MSc3 Hadi Ostadi Moghaddam, PhD1 • Abbas Ali Yekta, PhD1 • Habibollah Esmaily, PhD4 Evaluation of Contrast Sensitivity, Color Vision and Visual Acuity in Patients with and without Diabetes, Iranian Journal of Ophthalmology 2010; 22 (3):33-40 © 2010 by the Iranian Society of Ophthalmology

Ghafour M, Foulds WS, Allan D, Mc Clure F. Contrast sensitivity in diabetic subjects with and without retinopathy. Br JOphthalmol 1982; 66: 492-5.

Beszédesová N, Budinská E, Skorkovská S. [Functional integrity of neural retina in 2. type diabetics]. Cesk Slov Oftalmol. 2009 Jul; 65(4):124-30.

Abrishami M, Heravian J, Derakhshan A, Mousavi M, Banaee T, Daneshvar R, Moghaddam HO. Abnormal Cambrid gelow-contrast grating sensitivity results associated with diabetic retinopathy as a potential screening tool. East Mediterr Health J. 2007 Jul-Aug; 13(4):810-8.

Dosso AA, Bonvin ER, Morel Y, Golay A, Assal JP, Leuenberger PM. Risk factors associated with contrast sensitivity loss in diabetic patients. Graefes Arch ClinExpOphthalmol 1996 May; 234(5):3005.

Mackie SW, Walsh G. Contrast and glare sensitivity in diabetic patients with and without panretinal photocogulation. Ophthalmic Physiol Opt 1998 Mar; 18(2): 173-81.

North RV, Farrell U, Banford D, Jones C, Gregory JW, Butler G, Owens DR. Visual function in young DDM patients over 8 years of age. A 4-year longitudinal study. Diabetes Care. 1997 Nov; 20 (11): 1724-30.

Lobo CL, Bernardes RC, Figueira JP, de Abreu JR, Cunha-VazJGl. Three-year follow-up study of blood-retinal barrier and retinal thickness alterations in patients with type 2 diabetes mellitus and mild non prolife rative diabetic retinopathy. Arch Ophthalmol 2004; 122(2):211-7. 24.

Lövestam-Adrian M, Svendenius N, Agardh E. Contrast sensitivity and visual recovery time in diabetic patient streated with panretinal photocoagulation. Acta Ophthalmol Scand.2000Dec;78(6):672-6.

Wong R, Khan J, Adewoyin T, Sivaprasad S, Arden GB, Chong V. The ChromaTest, a digitalcolorcontrast sensitivity analyzer, for diabetic maculopathy: a pilot study. BMC Ophthalmol.2008 Aug 17;8:15. doi: 10. 1186/1471-2415-8-15.

Holopigian K, Greenstein VC, Seiple W, Hood DC, Carr RE. Evidence for photoreceptorchanges in patients with diabetic retinopathy. Invest Ophthalmol Vis Sci. 1997Oct; 38(11):2355-65.


  • There are currently no refbacks.